Our study demonstrated that, in addition to FGF7 mRNA, the FGF7 protein was also significantly upregulated in the tumors compared to ascites in two replicates of the mouse model, a syngeneic immunocompetent mouse model and clinical specimens collected from patients with ovarian cancer. Here, FGF7 is linked to ovarian cancer.